COVID Olfactory Trial Hints at Possible Benefit

Small sample size limits significance of findings

Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions

Full article: Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review

Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness - The Lancet Respiratory Medicine

Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments

MASH-COVID Trial Hints at Role for Targeting GM-CSF in Hyperinflammatory COVID-19

Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2, British Journal of Nutrition

Intranasal Insulin for the Treatment of Persistent Post‐COVID‐19 Olfactory Dysfunction - Cherobin - 2023 - Otolaryngology–Head and Neck Surgery - Wiley Online Library

COVID-19 and the Chemical Senses: Supporting Players Take Center Stage - ScienceDirect

Frontiers Loss of Olfactory Function—Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders

Post-viral olfactory loss and parosmia

Gabapentin No Help for Lingering COVID-Induced Olfactory Dysfunction

Pathogens, Free Full-Text

Two Years into the COVID-19 Pandemic: Lessons Learned

Anosmia and loss of smell in the era of covid-19